NXEN (Nexien BioPharma) Common Stock: $0.01 Mil (As of Mar. 2025)


What is Nexien BioPharma Common Stock?

Nexien BioPharma NXEN Common Stock is $0.01 Mil as of Mar. 2025.

Nexien BioPharma's quarterly common stock stayed the same from Sep. 2024 ($0.01 Mil) to Dec. 2024 ($0.01 Mil) and stayed the same from Dec. 2024 ($0.01 Mil) to Mar. 2025 ($0.01 Mil).

Nexien BioPharma's annual common stock stayed the same from Jun. 2022 ($0.01 Mil) to Jun. 2023 ($0.01 Mil) but then increased from Jun. 2023 ($0.01 Mil) to Jun. 2024 ($0.01 Mil).

Nexien BioPharma Common Stock Historical Data

* Premium members only.

The historical data trend for Nexien BioPharma's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nexien BioPharma Common Stock Chart

Nexien BioPharma Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Common Stock
Get a 7-Day Free Trial 0.01 0.01 0.01 0.01 0.01

Nexien BioPharma Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.01 0.01 0.01 0.01

Nexien BioPharma Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $0.01 Mil mean?
Nexien BioPharma (NXEN) has a Common Stock of $0.01 Mil as of Mar. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Nexien BioPharma and its competitors.
Is Nexien BioPharma's Common Stock too high?
Nexien BioPharma's current Common Stock is $0.01 Mil.
How does Nexien BioPharma's Common Stock compare to FLHLF and ZTS?
Nexien BioPharma's Common Stock of $0.01 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Drug Manufacturers company?
A good Common Stock depends on the Drug Manufacturers industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Nexien BioPharma and its competitors. Nexien BioPharma's current Common Stock is $0.01 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nexien BioPharma stock overvalued right now?
Nexien BioPharma (NXEN) has a current Common Stock of $0.01 Mil. The current Common Stock is $0.01 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Nexien BioPharma (NXEN), the current Common Stock is $0.01 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nexien BioPharma Business Description

Address 4340 East Kentucky Avenue, Suite 206, Glendale, CO, USA, 80246
Nexien BioPharma Inc is engaged in pre-clinical and drug development activities, by U.S. Food and Drug Administration (FDA) protocols, for certain pharmaceutical formulations that include cannabinoids. The company is pursuing the formulation and development of drugs containing cannabinoids for the treatment of various diseases, disorders, and medical conditions.